Rare Disease Endpoint Advancement Pilot Program

[FDA]

FDA is establishing a Rare Disease Endpoint Advancement (RDEA) Pilot Program to support novel efficacy endpoint development for drugs that treat rare diseases. The RDEA Pilot Program fulfills a commitment under PDUFA VII


Baca selengkapnya di : http://www.fda.gov...